Rhythm Pharmaceuticals buy Canaccord Genuity Group Inc.
Start price
02.03.23
/
50%
€21.20
Target price
02.03.24
€52.93
Performance (%)
85.85%
End price
03.03.24
€39.40
Summary
This prediction ended on 03.03.24 with a price of €39.40. With a performance of 85.85% the BUY prediction by Canaccord_Genuity_Gr was a big success. Canaccord_Genuity_Gr has a follow-up prediction for Rhythm Pharmaceuticals where he still thinks Rhythm Pharmaceuticals is a Buy. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Rhythm Pharmaceuticals | 5.369% | 5.369% | 46.729% | 400.000% |
| iShares Core DAX® | 1.110% | 3.983% | 5.623% | 49.883% |
| iShares Nasdaq 100 | 3.273% | 5.224% | 41.156% | 91.989% |
| iShares Nikkei 225® | 5.782% | 11.577% | 64.348% | 72.788% |
| iShares S&P 500 | 1.635% | 2.445% | 27.360% | 66.765% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at Canaccord Genuity Group Inc. from $52.00 to $56.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
In the thread Trading Rhythm Pharmaceuticals
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by Canaccord_Genuity_Gr for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€81.50
02.03.26
02.03.26
€118.79
02.03.27
02.03.27
-5.52%
09:32
09:32
